Novartis AG - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US66987V1098

SecurityNVS / Novartis AG - Depositary Receipt (Common Stock)
InstitutionWelch Group, LLC
Latest Disclosed Ownership9,466 shares
Latest Disclosed Value $ 1,445,932
Welch Group, LLC reports 1.97% decrease in ownership of NVS / Novartis AG - Depositary Receipt (Common Stock)

On April 21, 2026 - Welch Group, LLC filed a 13F-HR form disclosing ownership of 9,466 shares of Novartis AG - Depositary Receipt (Common Stock) (US:NVS) valued at $1,445,932 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 9,656 shares of Novartis AG - Depositary Receipt (Common Stock). This represents a change in shares of -1.97% during the quarter. The current value of the position is $1,411,949 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F NOVARTIS COMMON 66987V109 9,466 -190 -1.97 1,446 8.56 0.0543
2026-01-26 2025-12-31 13F NOVARTIS COMMON STOCK 66987V109 9,656 190 2.01 1,331 9.73 0.0513
2025-10-14 2025-09-30 13F NOVARTIS COMMON 66987V109 9,466 0 0.00 1,214 5.94 0.0474
2025-07-25 2025-06-30 13F NOVARTIS COMMON 66987V109 9,466 20 0.21 1,145 7.71 0.0479
2025-04-08 2025-03-31 13F NOVARTIS COMMON 66987V109 9,446 -12 -0.13 1,063 15.54 0.0468
2025-01-27 2024-12-31 13F NOVARTIS COMMON 66987V109 9,458 -384 -3.90 921 -18.73 0.0415
2024-10-24 2024-09-30 13F NOVARTIS COMMON 66987V109 9,842 -384 -3.76 1,132 4.04 0.0492
2024-07-17 2024-06-30 13F NOVARTIS COMMON 66987V109 10,226 0 0.00 1,089 10.01 0.0523
2024-04-09 2024-03-31 13F NOVARTIS COMMON 66987V109 10,226 -556 -5.16 989 -9.10 0.0491
2024-01-23 2023-12-31 13F NOVARTIS Common 66987V109 10,782 -123 -1.13 1,089 -1.98 0.0586
2023-10-18 2023-09-30 13F NOVARTIS Common 66987V109 10,905 -888 -7.53 1,111 -6.72 0.0658
2023-07-18 2023-06-30 13F NOVARTIS Common 66987V109 11,793 0 0.00 1,190 9.78 0.0682
2023-04-13 2023-03-31 13F NOVARTIS Common 66987V109 11,793 -1,316 -10.04 1,085 -8.83 0.0631
2023-01-30 2022-12-31 13F NOVARTIS Common 66987V109 13,109 -448 -3.30 1,189 15.44 0.0680
2022-10-13 2022-09-30 13F NOVARTIS COMMON 66987V109 13,557 0 0.00 1,030 -10.12 0.0670
2022-07-21 2022-06-30 13F NOVARTIS COMMON 66987V109 13,557 -1,384 -9.26 1,146 -12.59 0.0699
2022-04-29 2022-03-31 13F NOVARTIS COMMON 66987V109 14,941 -1,664 -10.02 1,311 -9.71 0.0748
2022-01-26 2021-12-31 13F NOVARTIS COMMON 66987V109 16,605 -8,571 -34.04 1,452 -29.48 0.0849
2021-11-05 2021-09-30 13F NOVARTIS COMMON 66987V109 25,176 -354,635 -93.37 2,059 -94.06 0.1394
2021-07-21 2021-06-30 13F NOVARTIS COMMON 66987V109 379,811 16,047 4.41 34,654 11.45 2.3627
2021-04-23 2021-03-31 13F NOVARTIS COMMON 66987V109 363,764 4,124 1.15 31,095 -8.44 2.2383
2021-01-25 2020-12-31 13F NOVARTIS Common 66987V109 359,640 4,726 1.33 33,961 10.04 2.7239
2020-10-28 2020-09-30 13F NOVARTIS Common 66987V109 354,914 9,485 2.75 30,863 2.30 2.6962
2020-07-22 2020-06-30 13F NOVARTIS Common 66987V109 345,429 2,911 0.85 30,170 6.83 2.8185
2020-04-28 2020-03-31 13F NOVARTIS A G Common 66987V109 342,518 15,040 4.59 28,241 -8.93 3.0129
2020-01-24 2019-12-31 13F Novartis A G Spon Adr Common 66987V109 327,478 3,118 0.96 31,009 10.01 3.0511
2019-11-05 2019-09-30 13F Novartis A G Spon Adr Common 66987V109 324,360 -7,608 -2.29 28,187 -7.01 2.8952
2019-07-11 2019-06-30 13F Novartis A G Spon Adr Common 66987V109 331,968 38,068 12.95 30,312 7.28 3.2349
2019-04-15 2019-03-31 13F Novartis A G Spon Adr Common 66987V109 293,900 -1,747 -0.59 28,256 11.38 3.1105
2019-01-10 2018-12-31 13F Novartis A G Spon Adr Common 66987V109 295,647 3,442 1.18 25,369 0.77 3.1080
2018-11-01 2018-09-30 13F Novartis A G Spon Adr Common 66987V109 292,205 7,816 2.75 25,176 17.19 2.6221
2018-07-30 2018-06-30 13F Novartis A G Spon Adr Common 66987V109 284,389 9,801 3.57 21,483 -3.23 2.6759
2018-04-23 2018-03-31 13F Novartis A G Spon Adr Common 66987V109 274,588 70,401 34.48 22,200 29.49 2.8110
2018-02-01 2017-12-31 13F Novartis A G Spon Adr Common 66987V109 204,187 -2,698 -1.30 17,144 -3.47 2.6595
2017-11-07 2017-09-30 13F Novartis A G Spon Adr Common 66987V109 206,885 755 0.37 17,761 3.23 2.9694
2017-08-07 2017-06-30 13F Novartis A G Spon Adr Common 66987V109 206,130 16,567 8.74 17,206 22.21 2.8698
2017-05-01 2017-03-31 13F Novartis A G Spon Adr Common 66987V109 189,563 21,607 12.86 14,079 15.08 2.6498
2017-02-09 2016-12-31 13F Novartis A G Spon Adr Common 66987V109 167,956 -1,367 -0.81 12,234 -8.50 2.3914
2016-10-28 2016-09-30 13F Novartis A G Spon Adr Common 66987V109 169,323 10,985 6.94 13,370 2.34 2.6569
2016-07-27 2016-06-30 13F Novartis A G Spon Adr Common 66987V109 158,338 -28,018 -15.03 13,064 -3.23 2.6604
2016-05-05 2016-03-31 13F Novartis A G Spon Adr Common 66987V109 186,356 17,749 10.53 13,500 -6.94 2.2542
2016-01-21 2015-12-31 13F Novartis A G Spon Adr Common 66987V109 168,607 3,691 2.24 14,507 -4.31 2.6048
2015-10-23 2015-09-30 13F Novartis A G Spon Adr COM 66987V109 164,916 4,012 2.49 15,160 -4.19 2.9300
2015-07-31 2015-06-30 13F Novartis A G Spon Adr Common 66987V109 160,904 -706 -0.44 15,823 -0.71 2.9954
2015-04-29 2015-03-31 13F Novartis A G Spon Adr Common 66987V109 161,610 2,147 1.35 15,936 7.85 2.9256
2015-01-20 2014-12-31 13F Novartis A G Spon Adr Common 66987V109 159,463 2,869 1.83 14,776 0.24 2.8499
2014-10-29 2014-09-30 13F Novartis A G Spon Adr Common 66987V109 156,594 999 0.64 14,741 4.65 3.0469
2014-07-22 2014-06-30 13F Novartis A G Spon Adr Common 66987V109 155,595 778 0.50 14,086 7.01 2.9170
2014-04-23 2014-03-31 13F Novartis A G Spon Adr COM 66987V109 154,817 -2,023 -1.29 13,163 4.41 2.9809
2014-02-07 2013-12-31 13F Novartis A G Spon Adr Common 66987V109 156,840 1,726 1.11 12,607 5.95 2.8582
2013-10-04 2013-09-30 13F Novartis A G Spon Adr Common 66987V109 155,114 3,790 2.50 11,899 11.21 2.9248
2013-07-29 2013-06-30 13F Novartis A G Spon Adr Common 66987V109 151,324 151,324 10,700 2.7777
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.